Diclofenac Sodium
Product Images NDC 61919-575

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 61919-575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Directrx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Boxed Warning (Diclo575boxedwarning)

Boxed Warning (Diclo575boxedwarning)
This text discusses the risks associated with Nonsteroidal anti-inflammatory drugs (NSAIDs), including an increased risk of cardiovascular thrombotic events such as heart attack and stroke, as well as serious gastrointestinal adverse events such as inflammation, bleeding, ulceration, and perforation of the stomach or intestines which can be fatal. The risk of these events may occur early in treatment and increase with duration of use. Elderly patients have a higher risk of serious gastrointestinal events. Additionally, Diclofenac sodium delayed-release tablets are contraindicated in the setting of coronary artery bypass graft (CABG) surgery.*
FDA Label Image

Label (Diclofenacsodium575)

Label (Diclofenacsodium575)
This is a description of a medication called Diclofenac Sodium, represented in a prescription format of 50mg per tablet and 60 tablets in a bottle. The medication is also known as VOLTAREN-S1EE8 and each enteric-coated tablet contains Diclofenac Sodium USP 50mg. However, there seems to be some distorted text and numerical characters that could not be evaluated, so the overall information is limited.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.